Qyuns Therapeutics (2509 HK)

Qyuns Therapeutics is a biopharmaceutical company exclusively focused on developing and commercializing biological therapies for autoimmune and allergic diseases. The company's pipeline includes antibody drugs for dermatology, rheumatology, respiratory, and gastroenterology. Qyuns Therapeutics is headquartered in Taizhou, China, and was founded in 2015.